Charles B. Nemeroff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charles B. Nemeroff has a total of 545 co-authors. Here are the top co-authors by number of shared publications:
- Gregory A. Fonzo
Department of Psychiatry and Behavioral Sciences, The University of Texas at Austin Dell Medical School, Austin, TX, USA
9 shared publications - D. Jeffrey Newport
University of Texas at Austin, Austin, TX, USA
7 shared publications - Boadie W. Dunlop
Emory University, Atlanta, GA, USA
6 shared publications - Kerry James Ressler
McLean Hospital
6 shared publications D. Jeffrey Newport
Department of Psychiatry and Behavioral Sciences, University of Texas at Austin Dell Medical School, Austin
5 shared publications- Elisabeth B. Binder
Max Planck Institute of Psychiatry
5 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Springer Nature in Research Square
Profiling Transcriptomic Changes Across Frontal Cortical Subregions in Major Depressive Disorder
Major depressive disorder (MDD) involves frontal cortical dysfunction, with emerging evidence implicating gliovascular and immune mechanisms, yet its transcriptional signatures across subregions, cell-types, and molecular layers remain poorly defined. Here, we integrated bulk-tissue RNA-seq data from dlPFC, mPFC, and dACC (n = 286) to identify a conserved core transcriptional profile, anchored in downregulated interneuron markers, and upregulated immune and vascular genes, spatially enriched in leptomeninges and white matter. Concordantly, multiomic factor analysis revealed immune activation, stress-response, and accelerated aging in MDD. Analysis of snRNA-seq data from dlPFC, mPFC, and oFC (863,511 nuclei; n = 204) revealed most pronounced MDD signatures in excitatory neurons, accompanied by coordinated disruption of glucocorticoid receptor machinery across cell-types, including FKBP5 upregulation. Glial, immune, and perivascular populations exhibited signatures of oxidative stress, ECM remodeling, and reduced neuronal support, and greater concordance with bulk-tissue MDD signals than neurons. A global reduction in cell-to-cell communications in MDD revealed a shift from homeostatic neuronal signaling toward endothelial and myelination-associated pathways. Ephrin-Eph signaling was consistently dysregulated, implicating disrupted axonal guidance, synaptic remodeling, and neurovascular integrity. Notably, MDD signatures were shared between MDD-only and PTSD comorbid cases at bulk-tissue analyses, while diverging at single-cell resolution. Together, these findings reframe MDD as a distributed frontal cortex disorder, driven by disrupted neuroglial and neurovascular communication.
- 8 October 2026
- Published by Springer Nature in Research Square
Open AccessProfiling Transcriptomic Changes Across Frontal Cortical Subregions in Major Depressive Disorder
Major depressive disorder (MDD) involves frontal cortical dysfunction, with emerging evidence implicating gliovascular and immune mechanisms, yet its transcriptional signatures across subregions, cell-types, and molecular layers remain poorly defined. Here, we integrated bulk-tissue RNA-seq data from dlPFC, mPFC, and dACC (n = 286) to identify a conserved core transcriptional profile, anchored in downregulated interneuron markers, and upregulated immune and vascular genes, spatially enriched in leptomeninges and white matter. Concordantly, multiomic factor analysis revealed immune activation, stress-response, and accelerated aging in MDD. Analysis of snRNA-seq data from dlPFC, mPFC, and oFC (863,511 nuclei; n = 204) revealed most pronounced MDD signatures in excitatory neurons, accompanied by coordinated disruption of glucocorticoid receptor machinery across cell-types, including FKBP5 upregulation. Glial, immune, and perivascular populations exhibited signatures of oxidative stress, ECM remodeling, and reduced neuronal support, and greater concordance with bulk-tissue MDD signals than neurons. A global reduction in cell-to-cell communications in MDD revealed a shift from homeostatic neuronal signaling toward endothelial and myelination-associated pathways. Ephrin-Eph signaling was consistently dysregulated, implicating disrupted axonal guidance, synaptic remodeling, and neurovascular integrity. Notably, MDD signatures were shared between MDD-only and PTSD comorbid cases at bulk-tissue analyses, while diverging at single-cell resolution. Together, these findings reframe MDD as a distributed frontal cortex disorder, driven by disrupted neuroglial and neurovascular communication.
- 18 September 2026
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (11) , 1642-1659
Early brain functional connectivity changes induced by antidepressants and placebo
- 18 September 2026
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (11) , 1642-1659
Early brain functional connectivity changes induced by antidepressants and placebo
- Open Access
- 12 May 2026
- Published by Elsevier in Psychiatry Research
- Vol. 364, 117225
Anhedonia in patients with major depressive disorder (MDD): State-of-the-art consensus review
- 12 May 2026
- Published by Elsevier in Psychiatry Research
- Vol. 364, 117225
Open AccessAnhedonia in patients with major depressive disorder (MDD): State-of-the-art consensus review
- 24 April 2026
- Published by American Psychiatric Association Publishing in The Journal of Neuropsychiatry and Clinical Neurosciences
- Vol. 38 (4) , 329-340
Relationships Among Dementia, Parental Death, and Other Adverse Childhood Experiences: Systematic Review and Meta-Analysis
Examining risk factors for the development of dementia, a devastating condition, is of increasing importance in clinical research. Adverse childhood experiences (ACEs) represent one set of potentially modifiable dementia risk factors with known impacts on neurodevelopment and health. Refining approaches used in previous reviews, the authors of this review and meta-analysis sought to answer the question, What is the strength of the association between ACEs and dementia in later life? The authors searched PubMed, EMBASE, and Web of Science, including peer-reviewed studies involving adults exposed to ACEs and a comparison group of unexposed adults. The outcome of interest was dementia of any etiology, and study quality was assessed. Separate meta-analyses were performed with odds ratios and hazard ratios (HRs). The literature search yielded 2,032 articles, of which 13 were included for analysis. ACE exposure (OR=1.54, 95% CI=1.38-1.71, p<0.001; HR=1.51, 95% CI=1.24-1.84, p<0.001) and exposure to parental death in childhood (OR=1.42, 95% CI=1.16-1.74, p<0.001) were associated with increased odds of or risk for developing dementia, respectively. This meta-analytic review is the most extensive examination of the ACE-dementia relationship to date, and its findings suggest that several ACEs are associated with increased dementia odds and risk. Although the number of studies reviewed was small and the studies were mostly of fair quality, necessitating caution in interpretation, nearly all of their results supported the association between ACE and dementia. High-quality prospective cohort studies incorporating biomarkers to measure ACE outcomes will be essential.
- 24 April 2026
- Published by American Psychiatric Association Publishing in The Journal of Neuropsychiatry and Clinical Neurosciences
- Vol. 38 (4) , 329-340
Relationships Among Dementia, Parental Death, and Other Adverse Childhood Experiences: Systematic Review and Meta-Analysis
Examining risk factors for the development of dementia, a devastating condition, is of increasing importance in clinical research. Adverse childhood experiences (ACEs) represent one set of potentially modifiable dementia risk factors with known impacts on neurodevelopment and health. Refining approaches used in previous reviews, the authors of this review and meta-analysis sought to answer the question, What is the strength of the association between ACEs and dementia in later life? The authors searched PubMed, EMBASE, and Web of Science, including peer-reviewed studies involving adults exposed to ACEs and a comparison group of unexposed adults. The outcome of interest was dementia of any etiology, and study quality was assessed. Separate meta-analyses were performed with odds ratios and hazard ratios (HRs). The literature search yielded 2,032 articles, of which 13 were included for analysis. ACE exposure (OR=1.54, 95% CI=1.38-1.71, p<0.001; HR=1.51, 95% CI=1.24-1.84, p<0.001) and exposure to parental death in childhood (OR=1.42, 95% CI=1.16-1.74, p<0.001) were associated with increased odds of or risk for developing dementia, respectively. This meta-analytic review is the most extensive examination of the ACE-dementia relationship to date, and its findings suggest that several ACEs are associated with increased dementia odds and risk. Although the number of studies reviewed was small and the studies were mostly of fair quality, necessitating caution in interpretation, nearly all of their results supported the association between ACE and dementia. High-quality prospective cohort studies incorporating biomarkers to measure ACE outcomes will be essential.
- Open Access
- 23 April 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Augmenting extinction with counterconditioning strengthens and sustains neural safety representations in PTSD
Because extinction forms the empirical foundation of exposure therapy, strategies to enhance extinction could lead to more effective interventions for posttraumatic stress disorder (PTSD). Here, we used functional MRI to compare immediate and long-term efficacy of enhanced versus standard extinction in 54 adults with (n = 32) and without (n = 22) PTSD. In both control and PTSD groups, counterconditioning—an enhanced form of extinction that replaces threat with positive outcomes—was more effective than standard extinction. It reduced threat-related neural activity and promoted reinstatement of safety (extinction) patterns in the ventromedial prefrontal cortex (a region involved in learning and retrieving safety associations). However, the PTSD group continued to reinstate both threat- and safety-related neural patterns in the dorsal anterior cingulate cortex (a region involved in learning and retrieving threat associations). These findings represent novel evidence that enhanced extinction outperforms standard extinction in promoting more rapid and persistent neural representations of safety in PTSD.
- 23 April 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessAugmenting extinction with counterconditioning strengthens and sustains neural safety representations in PTSD
Because extinction forms the empirical foundation of exposure therapy, strategies to enhance extinction could lead to more effective interventions for posttraumatic stress disorder (PTSD). Here, we used functional MRI to compare immediate and long-term efficacy of enhanced versus standard extinction in 54 adults with (n = 32) and without (n = 22) PTSD. In both control and PTSD groups, counterconditioning—an enhanced form of extinction that replaces threat with positive outcomes—was more effective than standard extinction. It reduced threat-related neural activity and promoted reinstatement of safety (extinction) patterns in the ventromedial prefrontal cortex (a region involved in learning and retrieving safety associations). However, the PTSD group continued to reinstate both threat- and safety-related neural patterns in the dorsal anterior cingulate cortex (a region involved in learning and retrieving threat associations). These findings represent novel evidence that enhanced extinction outperforms standard extinction in promoting more rapid and persistent neural representations of safety in PTSD.
- Open Access
- 16 April 2026
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (7) , 1351
Correction: Psychedelic therapeutics in psychiatric conditions
- 16 April 2026
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (7) , 1351
Open AccessCorrection: Psychedelic therapeutics in psychiatric conditions
- Open Access
- 18 February 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (3) , 522-529
Childhood Maltreatment in the Context of Familial Bipolar I Disorder Risk Predicts Major Depressive Disorder in Adolescents
- 18 February 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (3) , 522-529
Open AccessChildhood Maltreatment in the Context of Familial Bipolar I Disorder Risk Predicts Major Depressive Disorder in Adolescents
- Open Access
- 14 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 403, 121444
Implementing artificial intelligence (AI) to facilitate health outcomes in mood disorders: Application versus aspiration
- 14 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 403, 121444
Open AccessImplementing artificial intelligence (AI) to facilitate health outcomes in mood disorders: Application versus aspiration
- Open Access
- 12 February 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (2) , e63
Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century
Background: The relationship between media portrayal of psychedelic drugs, scientific research and drug policy is an area of debate. Aims: To apply artificial intelligence technology to measure trends in media sentiment towards the therapeutic potential of psychedelic drugs. Method: Up to 300 of the most relevant articles from Google News searches for the term ‘psychedelics’ were sampled for each year from 2000 to 2025. A large language model, ChatGPT, evaluated subject matter and sentiment. Results: In total, 88.3% of screened URLs (3308 of 3747) were included in the analysis. The proportion of articles focusing on the therapeutic potential of psychedelics increased from 13.3% (26 of 198) from 2000 to 2009 to 85.3% (1254 of 1470) from 2020 to 2025. The average sentiment score from 2000 to 2025 for articles from all publications ( N = 2168) was 78.5 ± 9.3 (mean ± s.d.) (possible range: 1–100). 1.3% (29 of 2168) of articles carried negative sentiment (P < 0.00001, Mann–Whitney U -test). The proportion of negative-neutral articles (≤65) increased annually from a trough of 3.6% (8 of 267) in 2020 to a peak of 20.9% (43 of 253) in 2024. Artificial intelligence sentiment scores were correlated and concordant with average human rater scores ( r = 0.88, concordance correlation coefficient 0.84). Conclusions: Although most 21st-century media coverage of psychedelic drugs has been positively framed, negative and neutral coverage has increased in frequency since 2020. Researchers, clinicians, regulators and policy-makers should be mindful of the complex relationship between media portrayals of psychedelics and the results of scientific research.
- 12 February 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (2) , e63
Open AccessTrends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century
Background: The relationship between media portrayal of psychedelic drugs, scientific research and drug policy is an area of debate. Aims: To apply artificial intelligence technology to measure trends in media sentiment towards the therapeutic potential of psychedelic drugs. Method: Up to 300 of the most relevant articles from Google News searches for the term ‘psychedelics’ were sampled for each year from 2000 to 2025. A large language model, ChatGPT, evaluated subject matter and sentiment. Results: In total, 88.3% of screened URLs (3308 of 3747) were included in the analysis. The proportion of articles focusing on the therapeutic potential of psychedelics increased from 13.3% (26 of 198) from 2000 to 2009 to 85.3% (1254 of 1470) from 2020 to 2025. The average sentiment score from 2000 to 2025 for articles from all publications ( N = 2168) was 78.5 ± 9.3 (mean ± s.d.) (possible range: 1–100). 1.3% (29 of 2168) of articles carried negative sentiment (P < 0.00001, Mann–Whitney U -test). The proportion of negative-neutral articles (≤65) increased annually from a trough of 3.6% (8 of 267) in 2020 to a peak of 20.9% (43 of 253) in 2024. Artificial intelligence sentiment scores were correlated and concordant with average human rater scores ( r = 0.88, concordance correlation coefficient 0.84). Conclusions: Although most 21st-century media coverage of psychedelic drugs has been positively framed, negative and neutral coverage has increased in frequency since 2020. Researchers, clinicians, regulators and policy-makers should be mindful of the complex relationship between media portrayals of psychedelics and the results of scientific research.
- Open Access
- 10 February 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (6) , 3254-3256
TMS in adolescent depression: A milestone FDA clearance
- 10 February 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (6) , 3254-3256
Open AccessTMS in adolescent depression: A milestone FDA clearance